Next Quarterly Earnings
After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Sarepta Therapeutics is a leading US-based biotechnology company focused on developing and commercializing innovative gene therapies and RNA-based medicines. The company's primary focus is on rare neuromuscular diseases, such as Duchenne muscular dystrophy, aiming to improve the lives of patients globally.
After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Sarepta Therapeutics is scheduled to report its next quarterly earnings on 11/04/2026. After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Sarepta Therapeutics last reported quarterly earnings on 8/5/2026 (Q2 2026). Earnings per share (EPS) came in at -0.05 USD.
Across its last 3 earnings reports, Sarepta Therapeutics stock moved by ±17.1% on average the following day. The largest reaction was -33.7% on 11/03/2025; 0 of 3 reactions were positive.
Sarepta Therapeutics has beaten analyst EPS estimates in 3 of its last 5 evaluated quarters (beat rate: 60%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 3 report dates (close to close).
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.